Loading...
CareRx Corporation
CHHHF•PNK
Healthcare
Medical - Care Facilities
$2.05
$0.00(0.00%)
CareRx Corporation (CHHHF) Financial Performance & Income Statement Overview
Review CareRx Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.09%
↓ 1.09%
Operating Income Growth
-3.10%
↓ 3.10%
Net Income Growth
16.73%
↑ 16.73%
Operating Cash Flow Growth
38.78%
↑ 38.78%
Operating Margin
1.30%
↑ 1.30%
Gross Margin
29.53%
↑ 29.53%
Net Profit Margin
-1.03%
↓ 1.03%
ROE
-4.54%
↓ 4.54%
ROIC
2.93%
↑ 2.93%
CareRx Corporation (CHHHF) Income Statement & Financial Overview
Review CareRx Corporation's (CHHHF) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $89.55M | $92.18M | $92.84M | $91.97M |
Cost of Revenue | $62.96M | $64.84M | $65.80M | $64.70M |
Gross Profit | $26.59M | $27.34M | $27.03M | $27.27M |
Gross Profit Ratio | $0.30 | $0.30 | $0.29 | $0.30 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $8.36M | $9.84M | $8.05M | $25.46M |
Operating Expenses | $24.59M | $27.42M | $25.16M | $20.12M |
Total Costs & Expenses | $87.55M | $92.26M | $90.96M | $90.99M |
Interest Income | $36000.00 | $29000.00 | $32000.00 | $1000.00 |
Interest Expense | $1.78M | $2.14M | $2.24M | $2.34M |
Depreciation & Amortization | $4.76M | $4.78M | $4.77M | $4.82M |
EBITDA | $6.77M | $4.94M | $6.58M | $5.79M |
EBITDA Ratio | $0.08 | $0.05 | $0.07 | $0.06 |
Operating Income | $2.002M | -$81000.00 | $1.87M | $980000.00 |
Operating Income Ratio | $0.02 | -$0.001 | $0.02 | $0.01 |
Other Income/Expenses (Net) | -$1.77M | -$2.13M | -$2.23M | -$2.36M |
Income Before Tax | $227000.00 | -$2.21M | -$360000.00 | -$1.38M |
Income Before Tax Ratio | $0.003 | -$0.02 | -$0.004 | -$0.01 |
Income Tax Expense | $0.00 | $32000.00 | $0.00 | $0.00 |
Net Income | $227000.00 | -$2.25M | -$360000.00 | -$1.38M |
Net Income Ratio | $0.003 | -$0.02 | -$0.004 | -$0.01 |
EPS | $0.004 | -$0.04 | -$0.006 | -$0.02 |
Diluted EPS | $0.004 | -$0.04 | -$0.006 | -$0.02 |
Weighted Avg Shares Outstanding | $62.73M | $62.15M | $60.09M | $60.13M |
Weighted Avg Shares Outstanding (Diluted) | $65.19M | $62.15M | $60.09M | $60.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan